294 related articles for article (PubMed ID: 23812633)
1. Agonists of MAS oncogene and angiotensin II type 2 receptors attenuate cardiopulmonary disease in rats with neonatal hyperoxia-induced lung injury.
Wagenaar GT; Laghmani el H; Fidder M; Sengers RM; de Visser YP; de Vries L; Rink R; Roks AJ; Folkerts G; Walther FJ
Am J Physiol Lung Cell Mol Physiol; 2013 Sep; 305(5):L341-51. PubMed ID: 23812633
[TBL] [Abstract][Full Text] [Related]
2. Angiotensin II type 2 receptor ligand PD123319 attenuates hyperoxia-induced lung and heart injury at a low dose in newborn rats.
Wagenaar GT; Sengers RM; Laghmani el H; Chen X; Lindeboom MP; Roks AJ; Folkerts G; Walther FJ
Am J Physiol Lung Cell Mol Physiol; 2014 Aug; 307(3):L261-72. PubMed ID: 24951776
[TBL] [Abstract][Full Text] [Related]
3. Ambrisentan reduces pulmonary arterial hypertension but does not stimulate alveolar and vascular development in neonatal rats with hyperoxic lung injury.
Wagenaar GT; Laghmani el H; de Visser YP; Sengers RM; Steendijk P; Baelde HJ; Walther FJ
Am J Physiol Lung Cell Mol Physiol; 2013 Feb; 304(4):L264-75. PubMed ID: 23292811
[TBL] [Abstract][Full Text] [Related]
4. Selective activation of angiotensin AT2 receptors attenuates progression of pulmonary hypertension and inhibits cardiopulmonary fibrosis.
Bruce E; Shenoy V; Rathinasabapathy A; Espejo A; Horowitz A; Oswalt A; Francis J; Nair A; Unger T; Raizada MK; Steckelings UM; Sumners C; Katovich MJ
Br J Pharmacol; 2015 May; 172(9):2219-31. PubMed ID: 25522140
[TBL] [Abstract][Full Text] [Related]
5. Apelin attenuates hyperoxic lung and heart injury in neonatal rats.
Visser YP; Walther FJ; Laghmani el H; Laarse Av; Wagenaar GT
Am J Respir Crit Care Med; 2010 Nov; 182(10):1239-50. PubMed ID: 20622042
[TBL] [Abstract][Full Text] [Related]
6. Deficiency or inhibition of lysophosphatidic acid receptor 1 protects against hyperoxia-induced lung injury in neonatal rats.
Chen X; Walther FJ; van Boxtel R; Laghmani EH; Sengers RM; Folkerts G; DeRuiter MC; Cuppen E; Wagenaar GT
Acta Physiol (Oxf); 2016 Mar; 216(3):358-75. PubMed ID: 26495902
[TBL] [Abstract][Full Text] [Related]
7. Sildenafil attenuates pulmonary inflammation and fibrin deposition, mortality and right ventricular hypertrophy in neonatal hyperoxic lung injury.
de Visser YP; Walther FJ; Laghmani el H; Boersma H; van der Laarse A; Wagenaar GT
Respir Res; 2009 Apr; 10(1):30. PubMed ID: 19402887
[TBL] [Abstract][Full Text] [Related]
8. Metformin attenuates hyperoxia-induced lung injury in neonatal rats by reducing the inflammatory response.
Chen X; Walther FJ; Sengers RM; Laghmani el H; Salam A; Folkerts G; Pera T; Wagenaar GT
Am J Physiol Lung Cell Mol Physiol; 2015 Aug; 309(3):L262-70. PubMed ID: 26047641
[TBL] [Abstract][Full Text] [Related]
9. Synergism between Angiotensin receptors ligands: Role of Angiotensin-(1-7) in modulating AT
Patel S; Hussain T
Pharmacol Res Perspect; 2020 Dec; 8(6):e00667. PubMed ID: 33197136
[TBL] [Abstract][Full Text] [Related]
10. Angiotensin-(1-7) attenuates airway remodelling and hyperresponsiveness in a model of chronic allergic lung inflammation.
Magalhães GS; Rodrigues-Machado MG; Motta-Santos D; Silva AR; Caliari MV; Prata LO; Abreu SC; Rocco PR; Barcelos LS; Santos RA; Campagnole-Santos MJ
Br J Pharmacol; 2015 May; 172(9):2330-42. PubMed ID: 25559763
[TBL] [Abstract][Full Text] [Related]
11. Angiotensin II type 1 receptor blockade restores angiotensin-(1-7)-induced coronary vasodilation in hypertrophic rat hearts.
Souza ÁP; Sobrinho DB; Almeida JF; Alves GM; Macedo LM; Porto JE; Vêncio EF; Colugnati DB; Santos RA; Ferreira AJ; Mendes EP; Castro CH
Clin Sci (Lond); 2013 Nov; 125(9):449-59. PubMed ID: 23718715
[TBL] [Abstract][Full Text] [Related]
12. Phosphodiesterase 4 inhibition attenuates persistent heart and lung injury by neonatal hyperoxia in rats.
de Visser YP; Walther FJ; Laghmani el H; Steendijk P; Middeldorp M; van der Laarse A; Wagenaar GT
Am J Physiol Lung Cell Mol Physiol; 2012 Jan; 302(1):L56-67. PubMed ID: 21949154
[TBL] [Abstract][Full Text] [Related]
13. Counteraction between angiotensin II and angiotensin-(1-7) via activating angiotensin type I and Mas receptor on rat renal mesangial cells.
Xue H; Zhou L; Yuan P; Wang Z; Ni J; Yao T; Wang J; Huang Y; Yu C; Lu L
Regul Pept; 2012 Aug; 177(1-3):12-20. PubMed ID: 22561449
[TBL] [Abstract][Full Text] [Related]
14. The renin-angiotensin system and its vasoactive metabolite angiotensin-(1-7) in the mechanism of the healing of preexisting gastric ulcers. The involvement of Mas receptors, nitric oxide, prostaglandins and proinflammatory cytokines.
Pawlik MW; Kwiecien S; Ptak-Belowska A; Pajdo R; Olszanecki R; Suski M; Madej J; Targosz A; Konturek SJ; Korbut R; Brzozowski T
J Physiol Pharmacol; 2016 Feb; 67(1):75-91. PubMed ID: 27010897
[TBL] [Abstract][Full Text] [Related]
15. The angiotensin-converting enzyme 2/angiogenesis-(1-7)/Mas axis confers cardiopulmonary protection against lung fibrosis and pulmonary hypertension.
Shenoy V; Ferreira AJ; Qi Y; Fraga-Silva RA; Díez-Freire C; Dooies A; Jun JY; Sriramula S; Mariappan N; Pourang D; Venugopal CS; Francis J; Reudelhuber T; Santos RA; Patel JM; Raizada MK; Katovich MJ
Am J Respir Crit Care Med; 2010 Oct; 182(8):1065-72. PubMed ID: 20581171
[TBL] [Abstract][Full Text] [Related]
16. Recombinant CCN1 prevents hyperoxia-induced lung injury in neonatal rats.
Vaidya R; Zambrano R; Hummler JK; Luo S; Duncan MR; Young K; Lau LF; Wu S
Pediatr Res; 2017 Nov; 82(5):863-871. PubMed ID: 28700567
[TBL] [Abstract][Full Text] [Related]
17. AVE 0991, a non-peptide mimic of angiotensin-(1-7) effects, attenuates pulmonary remodelling in a model of chronic asthma.
Rodrigues-Machado MG; Magalhães GS; Cardoso JA; Kangussu LM; Murari A; Caliari MV; Oliveira ML; Cara DC; Noviello ML; Marques FD; Pereira JM; Lautner RQ; Santos RA; Campagnole-Santos MJ
Br J Pharmacol; 2013 Oct; 170(4):835-46. PubMed ID: 23889691
[TBL] [Abstract][Full Text] [Related]
18. Activation of the MAS receptor by angiotensin-(1-7) in the renin-angiotensin system mediates mesenteric vasodilatation in cirrhosis.
Grace JA; Klein S; Herath CB; Granzow M; Schierwagen R; Masing N; Walther T; Sauerbruch T; Burrell LM; Angus PW; Trebicka J
Gastroenterology; 2013 Oct; 145(4):874-884.e5. PubMed ID: 23796456
[TBL] [Abstract][Full Text] [Related]
19. Angiotensin Type 2 and Mas Receptor Activation Prevents Myocardial Fibrosis and Hypertrophy through the Reduction of Inflammatory Cell Infiltration and Local Sympathetic Activity in Angiotensin II-Dependent Hypertension.
Castoldi G; Carletti R; Ippolito S; Stella A; Zerbini G; Pelucchi S; Zatti G; di Gioia CRT
Int J Mol Sci; 2021 Dec; 22(24):. PubMed ID: 34948475
[TBL] [Abstract][Full Text] [Related]
20. Modulation of angiotensin II receptor expression during development and regression of hypoxic pulmonary hypertension.
Chassagne C; Eddahibi S; Adamy C; Rideau D; Marotte F; Dubois-Randé JL; Adnot S; Samuel JL; Teiger E
Am J Respir Cell Mol Biol; 2000 Mar; 22(3):323-32. PubMed ID: 10696069
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
